Paion - Edison Group

Popular Searches:

Your Previous Searches:

Recently Visited Pages:

Home
Equities
Equities
View All Equities
Equities by Sector

Consumer

Energy & Resources

Financials

Healthcare

Industrials

Investment Companies

Metals & Mining

Real Estate

TMT

Pharnext

MCap

1m

Last close

EUR0.10

▲ 0.03 (42.86%)

MoneyHero

MCap

USD60m

Last close

USD2.35

▲ 0.55 (30.56%)

MGI – Media and Games Invest

MCap

EUR235m

Last close

EUR1.50

▲ 0.35 (30.21%)
Sectors
Sectors
Investment Strategy
Investment Strategy
View All

Latest
Thematics
Thematics
View All Thematics

Latest
Audiovisual
Audiovisual
View All Audiovisual

Latest

Events
About Edison
About Edison
About Edison

Careers

“Edison’s accessible and high-quality research gives us the opportunity to communicate an independent perspective of Tyman to a wide variety of potential stakeholders.”

James Brotherton Financial Director — Tyman
Equity Research
Investor Relations
Contact us

Overview
Financials
Research
Thematics

Edison Investment Research is terminating coverage on Paion. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare |
Update

27.11.20

Paion — GA data enable an application for surgical use

Healthcare |
QuickView

15.10.20

Paion — Commercialisation of remimazolam underway

Healthcare |
research

24.08.20

Paion — Remimazolam: Three major approvals

Healthcare |
Update

07.07.20

Paion — ByFavo – poised for autumn US launch

Sector

Healthcare

Financials

Edison Investment Research is terminating coverage on Paion. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Update

Healthcare

13.08.18

Paion — Progressing towards filings in US and Japan

Update

Healthcare

10.11.17

Paion — US and Japan filings and EU Phase III on track

Update

Healthcare

14.08.17

Paion — Remimazolam set for commercialisation in 2019

Update

Healthcare

07.07.17

Paion — Positive data in bronchoscopy Phase III

Update

Healthcare

12.05.17

Paion — On track for two filings by mid-2018

Update

Healthcare

27.03.17

Paion — On track to file in US and Japan by mid-2018

research

Healthcare

27.01.17

Paion — Positive data in high-risk patients

Outlook

Healthcare

21.11.16

Paion — Update 21 November 2016

Update

Healthcare

05.07.16

Paion — Update 5 July 2016

Update

Healthcare

17.05.16

Paion — Update 17 May 2016

Update

Healthcare

17.02.16

Paion — Update 16 February 2016

Update

Healthcare

10.02.16

Paion — Update 9 February 2016

Update

Healthcare

18.11.15

Paion — Update 17 November 2015